Feverfew 125 mg
Natural health product licensed in Canada
- Licence holder
- WN Pharmaceuticals Ltd
- NPN or DIN-HM
- 80000200
- Status
- Active licence
- Licence date
- 2 December 2004
- Revision date
- Not provided
- Form
- Caplet
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Tanacetum parthenium | 125 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Stéarate de magnésium, Acide stéarique, Dihydrate dibasique de phosphate de calcium, Cellulose - microcrystalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Caplet ; maximum: 2 Caplet | Not specified |
Uses authorised in Canada
Traditionally used to help reduce the severity and/or frequency of migraine headaches and associated nausea and vomiting.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking blood thinners. Discontinue use if experiencing sore mouth or development of mouth ulcers and/or gastrointestinal discomfort.
- Contre-indications
Do not use if you are pregnant, breastfeeding, or if you are allergic to the Asteracae/Compositae (daisy) family.
Source
Official Health Canada record, licence 80000200
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.